<DOC>
	<DOCNO>NCT02772484</DOCNO>
	<brief_summary>The HS-1000 device , investigational intracranial monitoring device , potential safely quickly diagnose assess stroke ( potentially neurologic condition ) minimal discomfort patient . HS-1000 capability establish cerebral hemodynamic measurement suspect stroke within minute , assist appropriate management stroke , also provide objective diagnostic tool clinician monitor recovery .</brief_summary>
	<brief_title>An Evaluation Non-invasive ICP Monitoring Patients Undergoing Routine Care</brief_title>
	<detailed_description>A prospective study conduct patient suspect stroke and/or acute neurologic change treat Armenia Republican Medical Center . Male Female patient age 18 eligible enrollment study . Eligible patient legally authorize representative ( LAR ) approach consent participate study . An initial recording session use HeadSense HS-1000 device obtain upon admission hospital . During admission , 2-4 additional recording session HS-1000 complete . The end-point study collect 30-minute record 5 session adequate quality analysis 200 subject . This data correlate clinical finding obtain patient 's diagnosis treatment course . An ease-of-use questionnaire administer HS-1000 device operator ( ) obtain information regard function workflow aspect use HS-1000 acute set improve assessment , diagnosis treatment stroke . The data obtain HS-1000 recording analyze establish specific waveform pattern correlate brain physiology stroke .</detailed_description>
	<criteria>Male female subject , &gt; 18 year age Subjects suspect stroke and/or acute neurologic change admit Armenia Republican Medical Center Subject legally authorize representative ( per local regulation ) able willing comply requirement protocol Subject legally authorize representative ( per local regulation ) able understand sign write informed consent participate study Local ear infection Known allergy hypersensitivity test material contraindication test material Subjects currently enrol less 30 day postparticipation investigational device drug study ( ) , receive investigational agent ( ) Any condition may jeopardize study participation ( e.g. , abnormal clinical laboratory find ) interpretation study result , may impede ability obtain informed consent ( e.g. , mental condition )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>noninvasive monitoring</keyword>
</DOC>